National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Schroer L, Weirich S, Hammerstad M, Hersleth HP, Grønsberg IA, Hagen L, Slupphaug G, Malecki JM, Jeltsch A, Falnes PØ, Davydova E(2025) Orthologues of the human protein histidine methyltransferase METTL9 display distinct substrate specificities J Biol Chem, 110318(in press) DOI 10.1016/j.jbc.2025.110318, PubMed 40451431
Wensaas A, Blatti C, Terjesen T, Huhnstock S(2025) Long-term outcome of nonoperative treatment of Perthes' disease : only 19% total hip arthroplasty at a mean follow-up of 48 years Bone Joint J, 107-B(6), 657-662 DOI 10.1302/0301-620X.107B6.BJJ-2024-1310.R1, PubMed 40449542
Yao Z, Fang K, Liu G, Bjørås M, Jin VX, Wang J(2025) Integrated analysis of differential intra-chromosomal community interactions: A study of breast cancer Artif Intell Med, 167, 103180(in press) DOI 10.1016/j.artmed.2025.103180, PubMed 40449144